1.Department of Orthopaedics,Anyuan People′s Hospital of Ganzhou City in Jiangxi Province,Anyuan 342100,China;
2.Department of Orthopaedics,Ganxian People′s Hospital of Ganzhou City in Jiangxi Province,Ganxian 341000,China;
3.Department of pain,Yichun People′s Hospital in Jiangxi Province,Yichun 336000,China;
4.Department of Interventional vascular pain,the Second People′s Hospital of Hefei City in Anhui Province,Hefei 230011,China
摘要目的探讨中央型腰椎间盘突出症患者运用经皮椎间孔镜TESSYS技术治疗的应用价值。方法选取2016年5月~2017年5月在我院收治的120例中央型腰椎间盘突出症患者作为研究对象,根据随机分组原则分为观察组和对照组,每组各60例。观察组患者给予经皮椎间孔镜TESSYS技术治疗,对照组患者采用常规治疗。统计分析两组患者的疾病症状、生存质量及疼痛症状改善情况。结果在疾病症状改善方面,观察组患者改善的总有效率(93.3%)高于对照组(80.0%),差异有统计学意义(P<0.05);观察组患者的生理症状[(86.5±10.6)分]、躯体症状[(80.6±9.7)分]、睡眠状况[(87.6±9.9)分]及心理症状[(88.8±11.6)分]评分均明显高于对照组,差异有统计学意义(P<0.05);治疗后,观察组患者的 VAS 疼痛评分[(2.11±0.95)分]低于对照组[(2.95±0.89)分],差异有统计学意义(P<0.05)。结论中央型腰椎间盘突出症患者采用经皮椎间孔镜TESSYS技术治疗,可有效改善患者的疾病症状,提高患者的生存质量,并有效减轻患者的疼痛症状,可以积极普及推广。
Abstract:ObjectiveTo investigate the clinical value of percutaneous transforaminal endoscopy TESSYS in the treatment of central lumbar disc herniation.MethodsFrom May 2016 to May 2017,120 patients with central lumbar disc herniation treated in our hospital were selected as the subjects,and divided into observation group and control group according to the principle of randomization,60 cases in each group.The observation group was given percutaneous transforaminal endoscopic TESSYS technique,while the control group was treated by conventional therapy.The disease symptoms,quality of life and improvement of pain symptoms in the two groups were analyzed.ResultsThe total effective rate(93.3%)in the observation group was significantly higher than that in the control group (80.0%),the difference was statistically significant(P<0.05).The physical symptoms([86.5±10.6]points),somatic symptoms([80.6±9.7]points),sleep state([87.6±9.9]points)and psychological symptoms([88.8±11.6]points)were significantly higher than those in the control group,the differences were statistically significant(P<0.05).After treatment,VAS pain score([2.11±0.95]points)in the observation group was lower than that in the control group([2.95±0.89]points),the difference was statistically significant(P<0.05).ConclusionThe treatment of central lumbar disc herniation with TESSYS percutaneous transforaminal endoscopic surgery can effectively improve the symptoms of patients,improve the quality of life of patients,and effectively reduce the pain symptoms of patients.It can be actively popularized and popularized.
陈晓龙;钟勇;范周洪;项延淼. 经皮椎间孔镜TESSYS技术治疗中央型腰椎间盘突出症的效果评价[J]. 中国当代医药, 2018, 25(6): 53-55.
CHEN Xiao-long;ZHONG Yong;FAN Zhou-hong;XIANG Yan-miao. Evaluation of the effect of percutaneous transforaminal endoscopy TESSYS in the treatment of central lumbar disc herniation. 中国当代医药, 2018, 25(6): 53-55.